170 related articles for article (PubMed ID: 37280675)
21. Characterization of the human skeletal muscle glycogen synthase gene (GYS1) promoter.
Fredriksson J; Ridderstråle M; Groop L; Orho-Melander M
Eur J Clin Invest; 2004 Feb; 34(2):113-21. PubMed ID: 14764074
[TBL] [Abstract][Full Text] [Related]
22. Proteomic analysis of ribosomes: translational control of mRNA populations by glycogen synthase GYS1.
Fuchs G; Diges C; Kohlstaedt LA; Wehner KA; Sarnow P
J Mol Biol; 2011 Jul; 410(1):118-30. PubMed ID: 21570405
[TBL] [Abstract][Full Text] [Related]
23. Association of the glycogen synthase locus on 19q13 with NIDDM in Pima Indians.
Majer M; Mott DM; Mochizuki H; Rowles JC; Pedersen O; Knowler WC; Bogardus C; Prochazka M
Diabetologia; 1996 Mar; 39(3):314-21. PubMed ID: 8721777
[TBL] [Abstract][Full Text] [Related]
24. Metabolic Response of Triple-Negative Breast Cancer to Folate Restriction.
Coleman MF; O'Flanagan CH; Pfeil AJ; Chen X; Pearce JB; Sumner S; Krupenko SA; Hursting SD
Nutrients; 2021 May; 13(5):. PubMed ID: 34068120
[TBL] [Abstract][Full Text] [Related]
25. Gys1 antisense therapy rescues neuropathological bases of murine Lafora disease.
Ahonen S; Nitschke S; Grossman TR; Kordasiewicz H; Wang P; Zhao X; Guisso DR; Kasiri S; Nitschke F; Minassian BA
Brain; 2021 Nov; 144(10):2985-2993. PubMed ID: 33993268
[TBL] [Abstract][Full Text] [Related]
26. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
Vijay GV; Zhao N; Den Hollander P; Toneff MJ; Joseph R; Pietila M; Taube JH; Sarkar TR; Ramirez-Pena E; Werden SJ; Shariati M; Gao R; Sobieski M; Stephan CC; Sphyris N; Miura N; Davies P; Chang JT; Soundararajan R; Rosen JM; Mani SA
Breast Cancer Res; 2019 Mar; 21(1):37. PubMed ID: 30845991
[TBL] [Abstract][Full Text] [Related]
27. Comparative skeletal muscle histopathologic and ultrastructural features in two forms of polysaccharide storage myopathy in horses.
McCue ME; Armién AG; Lucio M; Mickelson JR; Valberg SJ
Vet Pathol; 2009 Nov; 46(6):1281-91. PubMed ID: 19605906
[TBL] [Abstract][Full Text] [Related]
28. An inducible glycogen synthase-1 knockout halts but does not reverse Lafora disease progression in mice.
Nitschke S; Chown EE; Zhao X; Gabrielian S; Petković S; Guisso DR; Perri AM; Wang P; Ahonen S; Nitschke F; Minassian BA
J Biol Chem; 2021; 296():100150. PubMed ID: 33277363
[TBL] [Abstract][Full Text] [Related]
29. The structural mechanism of human glycogen synthesis by the GYS1-GYG1 complex.
Fastman NM; Liu Y; Ramanan V; Merritt H; Ambing E; DePaoli-Roach AA; Roach PJ; Hurley TD; Mellem KT; Ullman JC; Green E; Morgans D; Tzitzilonis C
Cell Rep; 2022 Jul; 40(1):111041. PubMed ID: 35793618
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional regulation of pig GYS1 gene by glycogen synthase kinase 3β (GSK3β).
Wang Y; Wang Y; Zhong T; Guo J; Li L; Zhang H; Wang L
Mol Cell Biochem; 2017 Jan; 424(1-2):203-208. PubMed ID: 27785702
[TBL] [Abstract][Full Text] [Related]
31. MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer.
Yamashita N; Long M; Fushimi A; Yamamoto M; Hata T; Hagiwara M; Bhattacharya A; Hu Q; Wong KK; Liu S; Kufe D
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33495298
[TBL] [Abstract][Full Text] [Related]
32. Proliferation-associated long noncoding RNA, TMPO-AS1, is a potential therapeutic target for triple-negative breast cancer.
Mitobe Y; Ikeda K; Sato W; Kodama Y; Naito M; Gotoh N; Miyata K; Kataoka K; Sasaki H; Horie-Inoue K; Inoue S
Cancer Sci; 2020 Jul; 111(7):2440-2450. PubMed ID: 32437068
[TBL] [Abstract][Full Text] [Related]
33. Andrographolide suppresses the malignancy of triple-negative breast cancer by reducing THOC1-promoted cancer stem cell characteristics.
Chou YJ; Lin CC; Hsu YC; Syu JL; Tseng LM; Chiu JH; Lo JF; Lin CH; Fu SL
Biochem Pharmacol; 2022 Dec; 206():115327. PubMed ID: 36330949
[TBL] [Abstract][Full Text] [Related]
34. Shikonin inhibits triple-negative breast cancer-cell metastasis by reversing the epithelial-to-mesenchymal transition via glycogen synthase kinase 3β-regulated suppression of β-catenin signaling.
Chen Y; Chen ZY; Chen L; Zhang JY; Fu LY; Tao L; Zhang Y; Hu XX; Shen XC
Biochem Pharmacol; 2019 Aug; 166():33-45. PubMed ID: 31071331
[TBL] [Abstract][Full Text] [Related]
35. Increase in ADAR1p110 activates the canonical Wnt signaling pathway associated with aggressive phenotype in triple negative breast cancer cells.
Morales F; Pérez P; Tapia JC; Lobos-González L; Herranz JM; Guevara F; de Santiago PR; Palacios E; Andaur R; Sagredo EA; Marcelain K; Armisén R
Gene; 2022 Apr; 819():146246. PubMed ID: 35122924
[TBL] [Abstract][Full Text] [Related]
36. Integrin α9 depletion promotes β-catenin degradation to suppress triple-negative breast cancer tumor growth and metastasis.
Wang Z; Li Y; Xiao Y; Lin HP; Yang P; Humphries B; Gao T; Yang C
Int J Cancer; 2019 Nov; 145(10):2767-2780. PubMed ID: 31008533
[TBL] [Abstract][Full Text] [Related]
37. Glucose utilization via glycogen phosphorylase sustains proliferation and prevents premature senescence in cancer cells.
Favaro E; Bensaad K; Chong MG; Tennant DA; Ferguson DJ; Snell C; Steers G; Turley H; Li JL; Günther UL; Buffa FM; McIntyre A; Harris AL
Cell Metab; 2012 Dec; 16(6):751-64. PubMed ID: 23177934
[TBL] [Abstract][Full Text] [Related]
38. MK8617 inhibits M1 macrophage polarization and inflammation
Qian L; Chen XQ; Kong D; Wang G; Cao Y; Xiao Y; Cao JY; Zou C
PeerJ; 2023; 11():e15591. PubMed ID: 37404479
[TBL] [Abstract][Full Text] [Related]
39. Beta 2 adrenergic receptor and mu opioid receptor interact to potentiate the aggressiveness of human breast cancer cell by activating the glycogen synthase kinase 3 signaling.
Rousseau B; Murugan S; Palagani A; Sarkar DK
Breast Cancer Res; 2022 May; 24(1):33. PubMed ID: 35568869
[TBL] [Abstract][Full Text] [Related]
40. Propolin G-Suppressed Epithelial-to-Mesenchymal Transition in Triple-Negative Breast Cancer Cells via Glycogen Synthase Kinase 3β-Mediated Snail and HDAC6-Regulated Vimentin Degradation.
Pai JT; Chen XH; Leu YL; Weng MS
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
